MedPath

Diagnosis of Cancer Using Breath Samples

Completed
Conditions
Cancer
Registration Number
NCT01234987
Lead Sponsor
Technion, Israel Institute of Technology
Brief Summary

The purpose of this study is to collect breath samples from healthy and cancer sick patients. The breath, collected to special bags, will be transferred to laboratories in the Technion and analyzed using an electronic nose system developed in Hossam Haick's labs (Chemical Engineering, Technion). The hypothesis is that based on the analysis of the chemical bio-markers present in the exhaled breath, cancer states can be distinguished from healthy subjects or before and after treatment, allowing a technique for diagnosis of cancer and/or cancer treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • The cancer is local or homeostatic
  • The subject did not undergo surgery for tumor removal, chemotherapy or radiation treatment prior to first sampling
  • The subject signed an informed consent form
Exclusion Criteria
  • The subject is addicted to drugs or alcohol
  • The subject smoked in the last hour
  • There are communication problems with the subject

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam Health Care Campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath